Title : Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years - Small_2005_Int.J.Clin.Pract_59_473 |
Author(s) : Small GW , Kaufer D , Mendiondo MS , Quarg P , Spiegel R |
Ref : Int J Clin Pract , 59 :473 , 2005 |
Abstract : |
PubMedSearch : Small_2005_Int.J.Clin.Pract_59_473 |
PubMedID: 15853867 |
Title : Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease - Burns_2004_Int.J.Geriatr.Psychiatry_19_243 |
Author(s) : Burns A , Spiegel R , Quarg P |
Ref : Int J Geriatr Psychiatry , 19 :243 , 2004 |
Abstract : |
PubMedSearch : Burns_2004_Int.J.Geriatr.Psychiatry_19_243 |
PubMedID: 15027039 |
Title : Disease stage in Alzheimer disease and treatment effects of rivastigmine - Kurz_2004_Alzheimer.Dis.Assoc.Disord_18_123 |
Author(s) : Kurz A , Farlow M , Quarg P , Spiegel R |
Ref : Alzheimer Disease & Associated Disorders , 18 :123 , 2004 |
Abstract : |
PubMedSearch : Kurz_2004_Alzheimer.Dis.Assoc.Disord_18_123 |
PubMedID: 15494617 |
Title : Rivastigmine in Alzheimer disease: efficacy over two years - Grossberg_2004_Am.J.Geriatr.Psychiatry_12_420 |
Author(s) : Grossberg G , Irwin P , Satlin A , Mesenbrink P , Spiegel R |
Ref : American Journal of Geriatry & Psychiatry , 12 :420 , 2004 |
Abstract : |
PubMedSearch : Grossberg_2004_Am.J.Geriatr.Psychiatry_12_420 |
PubMedID: 15249280 |
Title : Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients - Almkvist_2004_Eur.J.Neurol_11_253 |
Author(s) : Almkvist O , Darreh-Shori T , Stefanova E , Spiegel R , Nordberg A |
Ref : Eur Journal of Neurology , 11 :253 , 2004 |
Abstract : |
PubMedSearch : Almkvist_2004_Eur.J.Neurol_11_253 |
PubMedID: 15061827 |
Title : [Rivastigmine: a review of its clinical effectiveness] - Spiegel_2002_Rev.Neurol_35_859 |
Author(s) : Spiegel R |
Ref : Rev Neurol , 35 :859 , 2002 |
Abstract : |
PubMedSearch : Spiegel_2002_Rev.Neurol_35_859 |
PubMedID: 12436385 |
Title : Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit - Giacobini_2002_J.Neural.Transm.(Vienna)_109_1053 |
Author(s) : Giacobini E , Spiegel R , Enz A , Veroff AE , Cutler NR |
Ref : J Neural Transm (Vienna) , 109 :1053 , 2002 |
Abstract : |
PubMedSearch : Giacobini_2002_J.Neural.Transm.(Vienna)_109_1053 |
PubMedID: 12111443 |
Title : Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study - McKeith_2000_Lancet_356_2031 |
Author(s) : McKeith I , Del Ser T , Spano P , Emre M , Wesnes K , Anand R , Cicin-Sain A , Ferrara R , Spiegel R |
Ref : Lancet , 356 :2031 , 2000 |
Abstract : |
PubMedSearch : McKeith_2000_Lancet_356_2031 |
PubMedID: 11145488 |
Title : Effects of the novel acetylcholinesterase inhibitor SDZ ENA 713 on sleep in man - Holsboer-Trachsler_1993_Neuropsychopharmacology_8_87 |
Author(s) : Holsboer-Trachsler E , Hatzinger M , Stohler R , Hemmeter U , Gray J , Muller J , Kocher R , Spiegel R |
Ref : Neuropsychopharmacology , 8 :87 , 1993 |
Abstract : |
PubMedSearch : Holsboer-Trachsler_1993_Neuropsychopharmacology_8_87 |
PubMedID: 8424849 |
Title : Muscarinic agonists for senile dementia: past experience and future trends - Gray_1989_Trends.Pharmacol.Sci_Suppl_85 |
Author(s) : Gray JA , Enz A , Spiegel R |
Ref : Trends in Pharmacological Sciences , Suppl :85 , 1989 |
Abstract : |
PubMedSearch : Gray_1989_Trends.Pharmacol.Sci_Suppl_85 |
PubMedID: 2694530 |